Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 18 Source: CRO
- €161.4 million turnover
-
-€1.9 million
profit - 183 employees
-
31st Dec 17 Source: CRO
- €168.2 million turnover
-
€14.8 million
profit - 182 employees
- 7 more years available »
Ranking
By Turnover
(€161.4 million)- 360th in Top Companies
- 39th in Pharma
By Employees
(183)- 597th in Top Companies
- 56th in Pharma
-
- 183
- €161.4 million
Employees
- Riccardo Braglia CEO/Managing Director
Latest News
- Apr 03 Primark sets up fund for factory workers hit by Covid-19 order cancellations
- Apr 03 European shares decline over fears of deep recession
- Apr 03 Court rules Cox cannot access O’Flynn papers in legal dispute
- Apr 03 Camile restaurant chain stops paying rents ‘to safeguard future’
- Apr 03 Court finds musicians’ body has role in calculating amounts payable